Showing results (201-210 of 333) with videos related to

Sort By:
Pageof 34
Current Oncology (Toronto, Ont.)|November 24, 2022
Multidisciplinary Treatment of Liver Metastases from Intracranial SFTs/HPCs: A Report of Three Consecutive CasesFelix J Krendl, Franka Messner, Gregor Laimer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2005
The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancerDominik Wolf, Anna M Wolf, Holger Rumpold, et al.
Immunology and Cell Biology|March 9, 2011
Reinforcement of cancer immunotherapy by adoptive transfer of cblb-deficient CD8+ T cells combined with a DC vaccineChristina Lutz-Nicoladoni, Stephanie Wallner, Patrizia Stoitzner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 21, 2009
The sphingosine 1-phosphate receptor agonist FTY720 potently inhibits regulatory T cell proliferation in vitro and in vivoAnna Maria Wolf, Kathrin Eller, Robert Zeiser, et al.
Neuropsychologia|December 17, 2023
Interhemispheric transfer time correlates with white matter integrity of the corpus callosum in healthy older adultsDavid Riedel, Nicolai Lorke, Tim Fellerhoff, et al.
International Journal of Cancer|June 21, 2026
Primary Myelofibrosis (PMF)-The German ONKOPEDIA Guideline 2025Martin Griesshammer, Haifa Kathrin Al-Ali, Gabriela M Baerlocher, et al.
International Journal of Cancer|June 21, 2026
The German ONKOPEDIA Guideline for Myelofibrosis in 2025-Recommendations of an MPN Expert Panel of the German Society for Hematology and Oncology (DGHO)Martin Griesshammer, Haifa Kathrin Al-Ali, Gabriela M Baerlocher, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 2010
IL-9 production by regulatory T cells recruits mast cells that are essential for regulatory T cell-induced immune suppressionKathrin Eller, Dominik Wolf, Julia M Huber, et al.
Pageof 34